Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.42 USD | +0.45% | +2.33% | +144.44% |
03-22 | H.C. Wainwright Adjusts Price Target on Pyxis Oncology to $7 From $4, Maintains Buy Rating | MT |
03-21 | Health Care Up on Drug Sales Optimism -- Health Care Roundup | DJ |
- Stock Market
- Equities
- PYXS Stock
- News Pyxis Oncology, Inc.